{"id":"https://openalex.org/W978905256","doi":null,"title":"Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.","display_name":"Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W978905256","mag":"978905256","pmid":"https://pubmed.ncbi.nlm.nih.gov/26221907"},"language":"en","primary_location":{"id":"pmid:26221907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26221907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W978905256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"L Ordo\u00f1ez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165339363","display_name":"Universidad de Oviedo","ror":"https://ror.org/006gksa02","country_code":"ES","type":"education","lineage":["https://openalex.org/I165339363"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Ordo\u00f1ez","raw_affiliation_strings":["Department of Medicine, Pharmacology, Faculty of Medicine, University of Oviedo, Spain. gmanso@uniovi.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Pharmacology, Faculty of Medicine, University of Oviedo, Spain. gmanso@uniovi.es","institution_ids":["https://openalex.org/I165339363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013063589","display_name":"Esther Salgueiro","orcid":"https://orcid.org/0000-0003-4562-4290","observed_orcids":["https://orcid.org/0000-0003-4562-4290"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Salgueiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110314083","display_name":"Francisco J. Jimeno","orcid":"https://orcid.org/0000-0001-6510-6656","observed_orcids":["https://orcid.org/0000-0001-6510-6656"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F J Jimeno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042613251","display_name":"Gloria Manso","orcid":"https://orcid.org/0000-0002-9782-8888","observed_orcids":["https://orcid.org/0000-0002-9782-8888"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Manso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4517,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.77664565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"14","first_page":"2732","last_page":"2737"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":1.0},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9909999966621399},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8140000104904175},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9959999918937683},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9909999966621399},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":0.972000002861023},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":1.0},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9160000085830688}],"concepts":[{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.9545304179191589},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9463608264923096},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.9239509105682373},{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.8847980499267578},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.8349841833114624},{"id":"https://openalex.org/C2777332695","wikidata":"https://www.wikidata.org/wiki/Q417227","display_name":"Levetiracetam","level":3,"score":0.8166066408157349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7785258293151855},{"id":"https://openalex.org/C2777992146","wikidata":"https://www.wikidata.org/wiki/Q420383","display_name":"Primidone","level":4,"score":0.7201084494590759},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.7196750044822693},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.6669023633003235},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.6368168592453003},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5491346716880798},{"id":"https://openalex.org/C2777138316","wikidata":"https://www.wikidata.org/wiki/Q219957","display_name":"Zonisamide","level":4,"score":0.41378387808799744},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4052889943122864},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37458109855651855},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.342263400554657},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.2687884569168091},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1520109474658966},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078330","descriptor_name":"Oxcarbazepine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:26221907","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26221907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},{"id":"mag:978905256","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26221907","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2008784877","https://openalex.org/W3095130175","https://openalex.org/W2260572199","https://openalex.org/W2955051312","https://openalex.org/W2561353154","https://openalex.org/W2764236143","https://openalex.org/W2083008384","https://openalex.org/W2899577938","https://openalex.org/W7170047072","https://openalex.org/W2106351623"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"assess":[2],"the":[3,16,23,52,163,172,175,183,197],"association":[4,184],"between":[5],"Stevens-Johnson":[6],"syndrome":[7],"(SJS)/":[8],"toxic":[9],"epidermal":[10],"necrolysis":[11],"(TEN)":[12],"and":[13,40,49,58,61,78,104,120,131,147,158,195,201],"antiepileptics":[14],"including":[15],"most":[17,170],"recently":[18],"authorized":[19],"drugs.":[20,69],"METHODS:":[21],"In":[22],"Spanish":[24],"Pharmacovigilance":[25],"database,":[26],"we":[27],"searched":[28],"for":[29],"spontaneous":[30],"reports":[31,75],"of":[32,51,66,73,76,80,124,128,133,156,166,171,185,199],"SJS":[33,77,157,186],"or":[34,64,187,193,206],"TEN":[35,81,159,188],"associated":[36,92],"with":[37,93,189],"antiepileptic":[38,85,111],"drugs":[39,86,112],"analysed:":[41],"a)":[42],"reporting":[43],"odds":[44],"ratio":[45],"(ROR),":[46],"b)":[47],"age":[48,127],"gender":[50],"patient,":[53],"c)":[54],"evolution,":[55],"d)":[56],"latency":[57,154],"recovery":[59],"periods":[60],"e)":[62],"presence":[63],"absence":[65],"other":[67],"suspected":[68],"RESULTS:":[70],"A":[71],"total":[72],"84":[74],"80":[79],"related":[82,138],"to":[83,139,148],"9":[84],"were":[87,90,123,135,141],"studied.":[88],"Reports":[89],"mainly":[91],"phenytoin":[94,140],"(SJS:":[95,100,106],"28;":[96],"TEN:":[97,102,108],"43),":[98],"lamotrigine":[99,149,200],"37;":[101],"20)":[103],"carbamazepine":[105],"14;":[107],"16).":[109],"Other":[110],"involved":[113],"were:":[114],"valproate,":[115],"phenobarbital,":[116],"oxcarbazepine,":[117],"levetiracetam,":[118],"primidone":[119],"gabapentin.":[121],"Patients":[122],"a":[125],"median":[126],"40":[129],"[1-87]":[130],"57.3%":[132],"them":[134],"women.":[136,152],"Cases":[137],"more":[142],"common":[143],"in":[144,150,169],"older":[145],"men":[146],"younger":[151],"The":[153],"period":[155],"did":[160],"not":[161],"exceed":[162],"first":[164],"month":[165],"treatment":[167],"and,":[168],"analysed":[173],"reports,":[174],"outcome":[176],"was":[177],"recovery.":[178],"CONCLUSIONS:":[179],"Our":[180],"observations":[181],"support":[182],"phenytoin,":[190],"carbamazepine,":[191],"valproate":[192],"phenobarbital":[194],"enlighten":[196],"role":[198],"others":[202],"such":[203],"as":[204],"oxcarbazepine":[205],"levetiracetam.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W978905256","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
